Chemical Compound Review:
CHEMBL280450 N-methoxy-1-(1-methyl-5,6- dihydro-2H...
Synonyms:
CHEBI:120601, AC1O5KIP
- MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Jack, C.R., Slomkowski, M., Gracon, S., Hoover, T.M., Felmlee, J.P., Stewart, K., Xu, Y., Shiung, M., O'Brien, P.C., Cha, R., Knopman, D., Petersen, R.C. Neurology (2003)
- Interrater reliability of the Clinical Dementia Rating in a multicenter trial. Rockwood, K., Strang, D., MacKnight, C., Downer, R., Morris, J.C. Journal of the American Geriatrics Society. (2000)
- Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys. Callahan, M.J. Psychopharmacology (Berl.) (1999)
- Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. Schwarz, R.D., Callahan, M.J., Coughenour, L.L., Dickerson, M.R., Kinsora, J.J., Lipinski, W.J., Raby, C.A., Spencer, C.J., Tecle, H. J. Pharmacol. Exp. Ther. (1999)
- Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Hartvig, P., Nordberg, A., Torstenson, R., Sjöberg, P., Fasth, K.J., Långström, B. Dementia and geriatric cognitive disorders. (2002)
- Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT? Zheng, X.M. Journal of nuclear medicine technology. (2002)